Stewart Fisher

Chief Scientific Officer, C4 Therapeutics (United States).

Companies

C4 Therapeutics (United States)Chief Scientific Officer Oct 1, 2020 to Sep 17, 2024¹

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Sep 16, 2024Shares withheld for tax 661 shares at $6.36 of C4 Therapeutics (United States)²
Sep 16, 2024Exercised options 2,250 shares of C4 Therapeutics (United States)²
Feb 14, 2024Granted 27,300 shares of C4 Therapeutics (United States)³
Feb 13, 2024Shares withheld for tax 2,255 shares at $6.53 of C4 Therapeutics (United States)³
Aug 30, 2023Shares withheld for tax 661 shares at $2.93 of C4 Therapeutics (United States)⁴
Aug 30, 2023Exercised options 2,250 shares of C4 Therapeutics (United States)⁴
Feb 13, 2023Granted 26,000 shares of C4 Therapeutics (United States)⁵
Jan 30, 2023Shares withheld for tax 1,301 shares at $7.78 of C4 Therapeutics (United States)⁶
Jan 30, 2023Exercised options 3,750 shares of C4 Therapeutics (United States)⁶
May 26, 2022Shares withheld for tax 1,102 shares at $7.01 of C4 Therapeutics (United States)⁷
May 25, 2022Exercised options 3,750 shares of C4 Therapeutics (United States)⁸
Apr 12, 2022Exercised options 25,928 shares at $4.98 of C4 Therapeutics (United States)⁹
Apr 12, 2022Exercised options 2,156 shares at $3.71 of C4 Therapeutics (United States)⁹
Dec 8, 2021Exercised options 403 shares at $4.98 of C4 Therapeutics (United States)¹⁰
Dec 8, 2021Exercised options 17,786 shares at $3.71 of C4 Therapeutics (United States)¹⁰
Dec 8, 2021Exercised options 2,373 shares at $2.11 of C4 Therapeutics (United States)¹⁰

The numbers on this page point here. Each one links to the record it came from.